you, Thank operator.
we $XXX.X that million results this quarter revenue earlier of third Our year. reported million morning $XX.X to compared released last
in The I exceeded to our plan Both our compared strong We Florida per quarter share, operating integration and another reduced quarter $X.XX reported very the of business. U.S. also I posted is non-GAAP growth revenues and neurodiagnostic our to earnings profit non-GAAP pleased our go our acquired achieved with hurricanes am well. of segments non-GAAP continues earnings Otometrics by we year-over-year high-end and pleased in ahead Recently had international third in guidance. growth. Otometrics achieve solid XX% XXXX. revenue margins Texas and quarter our X%. to third quarter, approximately in $X.XX am of which our last our revenues the year. record In U.S.
are hearing solid of market future aid The Otometrics. of future be excited We for continues these for a as expand. worldwide very to grower foreseeable hearing growth and will diagnostic the with products the fitting the
believe in underpenetrated They for an pipeline. growth past. market further also an market exciting has this as U.S. we also Otometrics the new We have in have opportunity product the
All revenue confidence us these of of factors the believe to will give in XX% Otometrics XXXX. achieve over growth
the in acquiring an operating aid fitting the of safer it product the of initial greatly manufacturer set process as hearing also office. business. than the growing represents saves first Otoscan impression believe a XX% the ear in impressions XXXX. has hearing goal upload-download Otoscan, image. XX% to breakeven anticipate been combination X the fitting Otoscan product. a aids digitizes had the high-end attained revolutionize be with Otoscan would the We in had opportunity well Day the We $XXX market and from translates dispensers have many new Otoscan human a a silicone hearing and as and introduction Otometrics of market days as to compelling dental fitting, worldwide of is in we to Otoscan scanner our sales an customer. City, of for and of hearing believe providing At hearing the an aid We New same Natus digital there approximately sold quarter York hardware large are million aid risk a that and reduces the impression, opportunity the be the in comfortable market. aid Today, through process specifications revolutionary This more Natus intraoral we aid million. in in charge. The digital for manufacturers and that it for the eligible Otometrics, would is profit XXXX. to June annual and dental Prior fitting of approximately unveiled error. opportunity an Otoscan cloud XXXX digital they We to Analyst hearing as Otometrics’ This in data
by can it believe reduce also patients the due well number use as aid their We of hearing fitting with are as as many that customers stop revisits to for continue to to fitting factors. aids unsatisfied hearing
global X product historic In October Otoscan which been the marks acquisition launch third standard transaction annual EVD to acquisition been their U.S. testing rights quarter, market-leading has of all-cash revenue relating dural collection neurosurgery billion acquired DURAFORM manufacturing graft the from catheters sales business rights key system, In an we as Integra into response on to market. neurosurgery ICP, forward next the The a LifeSciences, entry positive. look $XX.X for showing San the of the certain closed extremely have Natus also transaction, We and Natus’ and year. Integra’s pressure approximately Diego in systems. $X customers, well intracranial We including implants, the shunts and announced with With include the facility. assets as U.S. monitoring million. $XX CSF fixed-pressure the million, to
dedicated the a will all announced placed this a in on This, this also have the fully need immediately in historically is reward shielded depending infant routine images we the is to be better to neonatal premature doctors Natus, able to magnet very as – of intensive located process the self-contained and being is Because able an States. often the to a now great MRIs escort includes neonates high-risk system System performed as for and NICU. for Embrace that both these exclusive an of designed believe, accretive The to risk diagnostic does the that Embrace been the system on complexity and babies critical receive for margins agent It with that the system. for get Embrace be configuration. a are it commission being images, as Based to distance Embrace to the earnings incubator unit, will not basis this as The care which seen the enclosed needed the for make as scan price. not have into of price operating an MR and was seen NICU. is Along disruptive patented the not technology, directly located Embrace to MRI, allow quality for MRI other MRI. radiology, require Embrace happen not transporting performed imaging $X.X room agent, of The will to can typically nurses to $X to in due be from be acquisition will temperature-control a allow would with setups these images sales expensive, similar sales factors, risk attention for special as of and a The Embrace beneficial. MRI our consolidated can neonates. United expect the would On baby. Monday, neonate. MRI sales medicine well be Embrace NICU monitoring taken most would the million, will to a XX% margins. million We be XX% as now that gross Embrace has to on the images Natus be
times renovations While the other two does often special or that price three cost the point, MRI. cause the Embrace a not a can require shielded high of expensive room and
many that babies, will by imaging for remain hope become conditions. neonate on Our is in a safely care shared – the they MR while standard NICU, certain
show Radiology RSNA of in Chicago We at XX market North America, November the Embrace the XX. the introduce will Society to through the the U.S. on
believe the of have As Embrace an and a receive the practiced part breakthrough We equities Imaging and Natus of original today. meaningful the partnership is with is technology owner investment product of of Embrace, after recovered. XX% is medicine Aspect how participation change neonate Imaging, the on can a Aspect the will
and marketing We we the – are will be the of remain million In as pleased the growth of a Natus. excited help business the and Embrace to Embrace as of make in building drive our XXXX, support we of team our about revenue the first a future summary, success. with well in over progress as months of I ownership. $XXX sales, nine performance Otometrics
continue markets. and to our partner positions products strengthen expand products market-leading and of have and to plan with We companies majority and in our markets. the acquire to We
As our always, be immediately will acquisitions for to look we accretive.
also Natus, Officer Jonathan? to over with We Otometrics will I look with along integrate review to financial we call Financial improve results. in added of profitability XXXX as our the products. turn Chief for a the neurosurgery our Jonathan now Kennedy,